Rare diseases
Investigational molecules
Locations
Liebigstrasse 20, Zentrum-Suedost, 04103 Leipzig, Germany
Universitaet Leipzig in Leipzig, Germany specialises in clinical trials of conditions such as Acute myeloid leukaemia, Myelodysplastic syndrome, Plasma cell myeloma, Oesophageal adenocarcinoma, and other specialisations. This site conducts important research.
At Universitaet Leipzig, clinical research in Dermatology, Venereology, and Allergology is centered on skin and connective tissue diseases, with a strong focus on ulcerative pyoderma gangrenosum. The trials are designed to assess whether new treatment approaches can improve outcomes for patients living with this rare and difficult-to-treat inflammatory condition.
With 6 clinical trials and 106 investigators contributing to the program, the site supports focused research on better therapies for this rare skin disease.
Clinical trials currently enrolling participants at this site.
Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyStudy of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo
GermanyGermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GermanyA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
GermanyA Study Testing How Well Bimekizumab Works and How Safe It Is for Adults with Palmoplantar Pustulosis
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
GermanyLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
GermanyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
